Author: Lauren Elder

Lauren is from New York and has a keen interest in advancing scientific and health communication having experience with marketing and copyright content projects in biotechnology and healthcare start-ups promoting new technologies, copyright content and regulation of promotional and educational pharmaceutical materials within FDA compliance standards.

Biotech

AI-Driven Biologics at Scale: Inside Juvena Therapeutics’ Regenerative Strategy

By

In the rapidly evolving field of regenerative medicine, Juvena Therapeutics stands out not just for its technology, but for its mission-driven leadership. Under the guidance of co-founder and CEO Dr. Hanadie Yousef, Juvena has emerged as a pioneer in developing biologics for rare and chronic diseases through a novel AI-enabled discovery platform. With the company’s recent regulatory and funding milestones, Juvena is carving a path at the intersection of artificial intelligence, protein science, and regenerative healthcare. From Discovery to Designation: Juvena’s Breakthrough Year Juvena Therapeutics capped off 2022 with a $41 million Series A financing round, led by Mubadala Capital…

Read More
MedTech

Wearables for Non-Invasive Neuromodulation Treatment of Essential Tremor

By

Cala Heath, Inc. is a bioelectronic medicine company that develops non-invasive neuromodulation therapies for chronic diseases through wearable devices. Their lead product, Cala Trio™ is FDA approved to treat essential tremor (ET), a neurological disorder that causes patients to experience involuntary rhythmic shaking in their hands, legs, head, trunk, or voice. ET is a progressive disease. Symptoms typically begin to appear when a person is in their 40s, and worsen with age. ET is a non-fatal diagnosis, however, symptoms can drastically hinder a person’s quality of life. The cause of ET is unknown, but it is believed that it may…

Read More